| dc.creator | da Silva Simoneti G. | |
| dc.creator | Saad S.T.O. | |
| dc.creator | Gilli S.C.O. | |
| dc.date | 2014 | |
| dc.date | 2015-06-25T18:01:18Z | |
| dc.date | 2015-11-26T15:03:04Z | |
| dc.date | 2015-06-25T18:01:18Z | |
| dc.date | 2015-11-26T15:03:04Z | |
| dc.date.accessioned | 2018-03-28T22:13:56Z | |
| dc.date.available | 2018-03-28T22:13:56Z | |
| dc.identifier | | |
| dc.identifier | Annals Of Clinical And Laboratory Science. Association Of Clinical Scientists, v. 44, n. 2, p. 180 - 188, 2014. | |
| dc.identifier | 917370 | |
| dc.identifier | | |
| dc.identifier | http://www.scopus.com/inward/record.url?eid=2-s2.0-84899716108&partnerID=40&md5=7500d801e9dac322273f5f7b8432ea2c | |
| dc.identifier | http://www.repositorio.unicamp.br/handle/REPOSIP/87546 | |
| dc.identifier | http://repositorio.unicamp.br/jspui/handle/REPOSIP/87546 | |
| dc.identifier | 2-s2.0-84899716108 | |
| dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1256524 | |
| dc.description | Protocols for the generation of dendritic cells (DCs) using serum as a supplementation of culture media leads to reactions due to animal proteins and disease transmissions. Several types of serum-free media (SFM), based on "good manufacture practices" (GMP), have recently been used and seem to be a viable option. The aim of this study was to evaluate the results of the differentiation, maturation, and function of DCs from Acute Myeloid Leukemia patients (AML), generated in SFM and medium supplemented with autologous serum (AS). DCs were analyzed by phenotype characteristics, viability, and functionality. The results showed the possibility of generating viable DCs in all the conditions tested. In patients, the X-VIVO 15 medium was more efficient than the other media tested in the generation of DCs producing IL-12p70 (p=0.05). Moreover, the presence of AS led to a significant increase of IL-10 by DCs as compared with CellGro (p=0.05) and X-Vivo15 (p=0.05) media, both in patients and donors. We concluded that SFM was efficient in the production of DCs for immunotherapy in AML patients. However, the use of AS appears to interfere with the functional capacity of the generated DCs. | |
| dc.description | 44 | |
| dc.description | 2 | |
| dc.description | 180 | |
| dc.description | 188 | |
| dc.description | Tallman, M.S., Gilliland, D.G., Rowe, J.M., Drug therapy for acute myeloid leukemia (2005) Blood, 106, pp. 1154-1163 | |
| dc.description | Arceci, R.J., The potential for antitumor vaccination in acute myelogenous leukemia (1998) J Mol Med (Berl), 76, pp. 80-93 | |
| dc.description | Lowdell, M.W., Koh, M.B., Immunotherapy of AML: future directions (2000) J Clin Pathol, 53, pp. 49-54 | |
| dc.description | Torelli, G.F., Orsini, E., Guarini, A., Kell, J., Foa, R., Developmental approaches in immunological control of acute myelogenous leukaemia (2001) Best Pract Res Clin Haematol, 14, pp. 189-209 | |
| dc.description | Balan, S., Kale, V.P., Limaye, L.S., A large number of mature and functional dendritic cells can be efficiently generated from umbilical cord blood-derived mononuclear cells by a simple twostep culture method Transfusion, 50, pp. 2413-2423 | |
| dc.description | Balan, S., Kale, V.P., Limaye, L.S., A simple two-step culture system for the large-scale generation of mature and functional dendritic cells from umbilical cord blood CD34+ cells (2009) Transfusion, 49, pp. 2109-2121 | |
| dc.description | Bender, A., Sapp, M., Schuler, G., Steinman, R.M., Bhardwaj, N., Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood (1996) J Immunol Methods, 196, pp. 121-135 | |
| dc.description | Romani, N., Gruner, S., Brang, D., Kampgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G., Schuler, G., Proliferating dendritic cell progenitors in human blood (1994) J Exp Med, 180, pp. 83-93 | |
| dc.description | Romani, N., Reider, D., Heuer, M., Ebner, S., Kampgen, E., Eibl, B., Niederwieser, D., Schuler, G., Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability (1996) J Immunol Methods, 196, pp. 137-151 | |
| dc.description | Tkachenko, N., Wojas, K., Tabarkiewicz, J., Rolinski, J., Generation of dendritic cells from human peripheral blood monocytes--comparison of different culture media (2005) Folia Histochem Cytobiol, 43, pp. 25-30 | |
| dc.description | Roddie, H., Klammer, M., Thomas, C., Thomson, R., Atkinson, A., Sproul, A., Waterfall, M., Turner, M., Phase I/II study of vaccination with dendritic-like leukaemia cells for the immunotherapy of acute myeloid leukaemia (2006) British journal of haematology, 133, pp. 152-157 | |
| dc.description | Charbonnier, A., Gaugler, B., Sainty, D., Lafage-Pochitaloff, M., Olive, D., Human acute myeloblastic leukemia cells differentiate in vitro into mature dendritic cells and induce the differentiation of cytotoxic T cells against autologous leukemias (1999) European journal of immunology, 29, pp. 2567-2578 | |
| dc.description | Choudhury, B.A., Liang, J.C., Thomas, E.K., Flores-Romo, L., Xie, Q.S., Agusala, K., Sutaria, S., Claxton, D.F., Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T-cell responses (1999) Blood, 93, pp. 780-786 | |
| dc.description | Kremser, A., Dressig, J., Grabrucker, C., Liepert, A., Kroell, T., Scholl, N., Schmid, C., Schmetzer, H., Dendritic cells (DCs) can be successfully generated from leukemic blasts in individual patients with AML or MDS: an evaluation of different methods J Immunother, 33, pp. 185-199 | |
| dc.description | van den Ancker, W., van Luijn, M.M., Westers, T.M., Bontkes, H.J., Ruben, J.M., de Gruijl, T.D., Ossenkoppele, G.J., van de Loosdrecht, A.A., Recent advances in antigen-loaded dendritic cell-based strategies for treatment of minimal residual disease in acute myeloid leukemia Immunotherapy, 2, pp. 69-83 | |
| dc.description | Kohler, T., Plettig, R., Wetzstein, W., Schmitz, M., Ritter, M., Mohr, B., Schaekel, U., Bornhauser, M., Cytokine-driven differentiation of blasts from patients with acute myelogenous and lymphoblastic leukemia into dendritic cells (2000) Stem cells (Dayton, Ohio), 18, pp. 139-147 | |
| dc.description | Panoskaltsis, N., Dendritic cells in MDS and AML--cause, effect or solution to the immune pathogenesis of disease? (2005) Leukemia, 19, pp. 354-357 | |
| dc.description | Royer, P.J., Tanguy-Royer, S., Ebstein, F., Sapede, C., Simon, T., Barbieux, I., Oger, R., Gregoire, M., Culture medium and protein supplementation in the generation and maturation of dendritic cells (2006) Scand J Immunol, 63, pp. 401-409 | |
| dc.description | Mackensen, A., Drager, R., Schlesier, M., Mertelsmann, R., Lindemann, A., Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells (2000) Cancer Immunol Immunother, 49, pp. 152-156 | |
| dc.description | Smits, E.L., Anguille, S., Cools, N., Berneman, Z.N., Van Tendeloo, V.F., Dendritic cell-based cancer gene therapy (2009) Hum Gene Ther, 20, pp. 1106-1118 | |
| dc.description | Anton, D., Dabadghao, S., Palucka, K., Holm, G., Yi, Q., Generation of dendritic cells from peripheral blood adherent cells in medium with human serum (1998) Scandinavian journal of immunology, 47, pp. 116-121 | |
| dc.description | Sorg, R.V., Ozcan, Z., Brefort, T., Fischer, J., Ackermann, R., Muller, M., Wernet, P., Clinical-scale generation of dendritic cells in a closed system (2003) J Immunother, 26, pp. 374-383 | |
| dc.description | Peng, J.C., Thomas, R., Nielsen, L.K., Generation and maturation of dendritic cells for clinical application under serum-free conditions (2005) J Immunother, 28, pp. 599-609 | |
| dc.description | Vicari, A.P., Caux, C., Trinchieri, G., Tumour escape from immune surveillance through dendritic cell inactivation (2002) Semin Cancer Biol, 12, pp. 33-42 | |
| dc.description | Onishi, H., Morisaki, T., Baba, E., Kuga, H., Kuroki, H., Matsumoto, K., Tanaka, M., Katano, M., Dysfunctional and short-lived subsets in monocyte-derived dendritic cells from patients with advanced cancer (2002) Clin Immunol, 105, pp. 286-295 | |
| dc.description | Kiertscher, S.M., Luo, J., Dubinett, S.M., Roth, M.D., Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells (2000) J Immunol, 164, pp. 1269-1276 | |
| dc.description | Krawczyk, P., Wojas, K., Milanowski, J., Rolinski, J., The influence of different culture microenvironments on the generation of dendritic cells from non-small-cell lung cancer patients (2007) Arch Immunol Ther Exp (Warsz), 55, pp. 405-415 | |
| dc.description | Kalinski, P., Vieira, P.L., Schuitemaker, J.H., de Jong, E.C., Kapsenberg, M.L., Prostaglandin E(2) is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer (2001) Blood, 97, pp. 3466-3469 | |
| dc.description | Ten Brinke, A., Karsten, M.L., Dieker, M.C., Zwaginga, J.J., van Ham, S.M., The clinical grade maturation cocktail monophosphoryl lipid A plus IFNgamma generates monocyte-derived dendritic cells with the capacity to migrate and induce Th1 polarization (2007) Vaccine, 25, pp. 7145-7152 | |
| dc.language | en | |
| dc.publisher | Association of Clinical Scientists | |
| dc.relation | Annals of Clinical and Laboratory Science | |
| dc.rights | fechado | |
| dc.source | Scopus | |
| dc.title | An Efficient Protocol For The Generation Of Monocyte Derived Dendritic Cells Using Serum-free Media For Clinical Applications In Post Remission Aml Patients | |
| dc.type | Artículos de revistas | |
